James P. Shaffer
2012
In 2012, James P. Shaffer earned a total compensation of $1.6M as Former Vice President and Chief Commercial Officer at Halozyme Therapeutics, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $44,952 |
|---|---|
| Option Awards | $106,182 |
| Salary | $352,567 |
| Stock Awards | $1,008,795 |
| Other | $52,045 |
| Total | $1,564,541 |
Shaffer received $1M in stock awards, accounting for 64% of the total pay in 2012.
Shaffer also received $45K in non-equity incentive plan, $106.2K in option awards, $352.6K in salary and $52K in other compensation.
Rankings
In 2012, James P. Shaffer's compensation ranked 4,425th out of 11,487 executives tracked by ExecPay. In other words, Shaffer earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,425 out of 11,487 | 62nd |
Division Manufacturing | 1,534 out of 4,253 | 64th |
Major group Chemicals And Allied Products | 351 out of 1,203 | 71st |
Industry group Drugs | 217 out of 925 | 77th |
Industry Biological Products, Except Diagnostic Substances | 38 out of 165 | 77th |
Source: SEC filing on April 3, 2015.
Shaffer's colleagues
We found five more compensation records of executives who worked with James P. Shaffer at Halozyme Therapeutics in 2012.
2012
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2012
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2012
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2012
Jean Liu
Halozyme Therapeutics
General Counsel
2012
David Ramsay
Halozyme Therapeutics